CAM USE and Cancer
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 1,356
- 试验地点
- 4
- 主要终点
- Proportion of patients who report that the health provider discussed complimentary and alternative medicine (CAM) use
研究概览
简要总结
RATIONALE: Educating health providers on talking with cancer patients about complementary and alternative medicine (CAM) may help encourage health providers to talk more often with cancer patients about the use of CAM.
PURPOSE: This randomized phase III trial is studying how well an education intervention works in encouraging health providers to talk with cancer patients about the use of CAM.
详细描述
OBJECTIVES:
Primary
- Examine the efficacy of an education intervention designed to increase the frequency with which health providers ask cancer patients about their use of complimentary and alternative medicine (CAM).
Secondary
- Examine the frequency with which health providers ask about CAM use and referral for CAM use by health providers.
- Evaluate whether personal CAM use among health providers is related to the frequency of asking patients about CAM use.
- Assess the frequency and type of CAM use among patients diagnosed with cancer.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Other
- 盲法
- Single (Participant)
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Proportion of patients who report that the health provider discussed complimentary and alternative medicine (CAM) use
时间窗: Baseline to 2 months
The Complementary and Alternative Medicine Patient Survey administered to patients to assess personal use of CAM before and after the cancer diagnosis as well as the level of interaction with providers regarding CAM use. Baseline survey assessment at one week and follow up assessment at 2 months.
次要结局
- Frequency with which health providers ask about CAM use and referral for CAM use by health providers(Baseline to 2 months)
- Relationship between personal CAM use among health providers and frequency of asking patients about CAM use(Baseline to 2 months)
- Frequency and type of CAM use among patients diagnosed with cancer(Up to 2 months)